003520.KO Yungjin Pharm Co Ltd

Healthcare Pharmaceuticals Korea Stock Exchange
866.00 KRW
Close of Nov 4, 2026
845.00 2,320
Market cap
KRW 158B
P/E
-
P/B
1.98x
ROE
-10.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 003520.KO undervalued?

Graham number

The Graham number of Yungjin Pharm Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Yungjin Pharm Co Ltd fundamental analysis

No fundamental analysis for Yungjin Pharm Co Ltd yet.

Yungjin Pharm Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Yungjin Pharm Co Ltd

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. The company offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. It also provides vitamins, minerals, and other products; and APIs. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pha…

Full company profile